Surface-immobilized aptamers for cancer cell isolation and microscopic cytology

Cancer Research

Volumn 70, Issue 22, 2010, Pages 9371-9380

  Wan, Yuan ^a,b   Kim, Young Tae ^a,b   Li, Na ^b,e   Cho, Steve K ^c,d,f   Bachoo, Robert ^c,d   Ellington, Andrew D ^b   Iqbal, Samir M ^a,b  

^a The University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e AM Biotechnologies   (United States)

^f Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CANCER CELL; CANCER SURVIVAL; CELL ISOLATION; CONTROLLED STUDY; CYTOLOGY; EMBRYO; EXON; GENETIC ENGINEERING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMOBILIZED CELL; MOUSE; MUTANT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; WILD TYPE;

ANIMALS; ANTIBODIES; APTAMERS, NUCLEOTIDE; ASTROCYTES; BASE SEQUENCE; BINDING, COMPETITIVE; BRAIN NEOPLASMS; CELL SEPARATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FIBROBLASTS; GLIOBLASTOMA; HUMANS; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MUTATION; NEURONS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, ANTISENSE; STEM CELLS; SURFACE PROPERTIES; TUMOR CELLS, CULTURED;

EID: 78549238601     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0568     Document Type: Article

References (43)

1. Mohamed H, McCurdy LD, Szarowski DH, et al. Development of a rare cell fractionation device: application for cancer detection. IEEE Trans Nanobioscience 2004;3:251-6.
2. Huang LR, Cox EC, Austin RH, et al. Continuous particle separation through deterministic lateral displacement. Science 2004;304:987-90.
3. Bustin SA, Gyselman VG, Siddiqi S, et al. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients. Int J Surg Invest 2000;2:49-57.
4. MacDonald MP, Neale S, Paterson L, et al. Cell cytometry with a light touch: sorting microscopic matter with an optical lattice. J Biol Regul Homeostatic Agents 2004;18:200-5.
5. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007;450:1235-9.
6. Feng J, Soper SA, McCarley RL, et al. Separation of breast cancer cells from peripherally circulating blood using antibodies fixed in microchannels. Proc SPIE 2004;5312:278-93.
7. Tibbe AG, de Grooth BG, Greve J, et al. Magnetic field design for selecting and aligning immunomagnetic labeled cells. Cytometry 2002;47:163-72.
8. Lee H, Sun E, Ham D, et al. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 2008;14:869-74.
9. He W, Wang H, Hartmann LC, et al. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U S A 2007;104:11760-5.
10. Toner M, Irimia D. Blood-on-a-chip. Annu Rev Biomed Eng 2005;7:77-103.
11. Baas IO, van den Berg FM, Mulder JW, et al. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J Pathol 1996;178:264-7.
12. Dalle F, Lopez J, Caillot D, et al. False-positive results caused by cotton swabs in commercial Aspergillus antigen latex agglutination test. Eur J Clin Microbiol Infect Dis 2002;21:130-2.
13. Bunka DH, Stockley PG. Aptamers come of age - at last. Nat Rev Microbiol 2006;4:588-96.
14. Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature 2002;418:252-8.
15. Farokhzad OC, Jon S, Khademhosseini A, et al. Nanoparticleaptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 2004;64:7668-72.
16. Chen HW, Medley CD, Sefah K, et al. Molecular recognition of small-cell lung cancer cells using aptamers. Chem Med Chem 2008;3:991-1001.
17. Nagel-Wolfrum K, Buerger C, Wittig I, et al. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Mol Cancer Res 2004;2:170-82.
18. Usman N, Blatt LM. Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics. J Clin Invest 2000;106:1197-202.
19. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 1997;4:809-16.
20. Bates PJ, Laber DA, Miller DM, et al. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 2009;86:151-64.
21. Phillips JA, Xu Y, Xia Z, et al. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal Chem 2008;81:1033-9.
22. Mendelsohn J. EGF receptors as a target for cancer therapy. Trans Am Clin Climatol Assoc 2004;115:249-53.
23. Franovic A, Gunaratnam L, Smith K, et al. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci U S A 2007;104:13092-7.
24. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Eng J Med 2008;359:366-77.
25. Chakravarti A, Loeffler JS, Dyson NJ. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 2002;62:200-7.
26. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193-216.
27. Carpenter G. The biochemistry and physiology of the receptorkinase for epidermal growth factor. Mol Cell Endocrinol 1983;31:1-19.
28. Wikstrand CJ, McLendon RE, Friedman AH, et al. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res 1997;57:4130-40.
29. Osborne SE, Matsumura I, Ellington AD. Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr Opin Chem Biol 1997;1:5-9.
30. Möller R, Csáki A, Köhler JM, et al. DNA probes on chip surfaces studied by scanning force microscopy using specific binding of colloidal gold. Nucleic Acids Res 2000;28:e91.
31. Iqbal SM, Akin D, Bashir R. Solid-state nanopore channels with DNA selectivity. Nat Nanotechnol 2007;2:243-8.
32. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, et al. Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem 2002;48:121-30.
33. Raj J, Herzog G, Manning M, et al. Surface immobilisation of antibody on cyclic olefin copolymer for sandwich immunoassay. Biosens Bioelectron 2009;24:2654-8.
34. Bachoo RM, Maher EA, Ligon KL, et al. Epidermal growth factor receptor and Ink4a/Arf Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002;1:269-77.
35. Kim Y, Karthikeyan K, Chirvi S, et al. Neuro-optical microfluidic platform to study injury and regeneration of single axons. Lab Chip 2009;9:2576-81.
36. Cheung LSL, Zheng X, Stopa A, et al. Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel. Lab Chip 2009;9:1721-31.
37. Morisaki H. A novel system for the analysis of cell attachment in Pseudomonas syringae. J Microbiol Methods 1995;22:69-78.
38. Hazen KC, Brawner DL, Riesselman MH, et al. Differential adherence between hydrophobic and hydrophilic yeast cells of Candida albicans. Infect Immun 1991;59:907-12.
39. Tamada Y, Ikada Y. Effect of preadsorbed proteins on cell adhesion to polymer surfaces. J Colloid Interface Sci 1993;155:334-9.
40. Kokoglulu E, Sonmez H, Uslu E, et al. Sialic acid levels in various types of cancer. Cancer Biochem Biophys 1992;13:57-64.
41. Khadapkar SV, Sheth NA, Bhide SV. Independence of sialic acid levels in normal and malignant growth. Cancer Res 1975;35:1520-3.
42. Sillanaukee P, Pönniö M, Jääskeläinen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest 1999;29:413-25.
43. Lekka M, Laidler P, Ignacak J, et al. The effect of chitosan on stiffness and glycolytic activity of human bladder cells. Biochim Biophys Acta 2001;1540:127-36.